Hygeia Healthcare Holdings Co., Limited executed an on-market repurchase of 311,200 ordinary shares on 29 May 2026, reducing its outstanding share count by 0.05% to 610.33 million shares. The shares were bought at prices ranging from HKD 9.53 to HKD 9.65, with a volume-weighted average cost of HKD 9.63 per share. Total consideration reached HKD 2.99 million.

Post-transaction, Hygeia Healthcare’s treasury stock balance increased to 8.17 million shares, while total issued shares remained at 618.50 million. The purchase forms part of the 61.85 million-share buy-back mandate approved on 27 June 2025; cumulative repurchases under this mandate now stand at 8.17 million shares, representing 1.32% of the company’s issued share capital at the mandate date.

In line with Hong Kong Stock Exchange regulations, the company is subject to a moratorium on new share issues or treasury-share sales until 28 June 2026.